Results 121 to 130 of about 610,892 (162)
Some of the next articles are maybe not open access.
Tumor necrosis: factors and principles
Immunology Today, 1996Abstract Tumor necrosis is often caused by vasculature shutdown, and the exploitation of altered features of the vasculature within solid tumors may give rise to novel forms of therapy. A recent meeting ∗ ∗The symposium ‘Tumor Necrosis: Factors and Principles' was held at Ringberg, Germany, on 29 October–1 November 1995.
D, Männel +3 more
openaire +2 more sources
Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies
Critical Care Medicine, 1993To review the relationship of tumor necrosis factor (TNF) to clinical sepsis and the clinical potential of anti-TNF therapy in decreasing morbidity and mortality rates due to sepsis.The international English language literature was reviewed, including animal studies and human clinical trials regarding TNF, anticytokine therapy, and sepsis.Studies which
J C, Wherry +2 more
openaire +2 more sources
Tumor necrosis factor and immunopathology
Immunologic Research, 1991Piguet PF, Grau GE, Vassalli P
openaire +3 more sources
Are There More Tumor Necrosis Factors?
JNCI Journal of the National Cancer Institute, 1989openaire +2 more sources
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Circulation, 1996Guillermo Torre-Amione, , Douglas Mann
exaly
BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth
Journal of Experimental Medicine, 1999Jeffrey Browning +2 more
exaly
Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium
Circulation, 1995Guillermo Torre-Amione, , Douglas Mann
exaly
Histoplasmosis after Treatment with Anti–Tumor Necrosis Factor-α Therapy
American Journal of Respiratory and Critical Care Medicine, 2003Chadi Hage +2 more
exaly